Ear stimulation device could tame rosacea flushing

NCT ID NCT07600424

Recruiting now Symptom relief Sponsor: Brigham and Women's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This pilot study will test whether a device that gently stimulates a nerve in the ear (taVNS) can reduce facial redness and flushing in people with rosacea. Ten adults with moderate-to-severe rosacea will use the device daily for 4 weeks, then be followed for another 4 weeks to see if any benefits last. The study measures changes in redness and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcutaneous auricular vagus nerve stimulation (taVNS) device
What this could lead to: If it works, this could point toward a drug-free way to reduce facial redness and flushing in rosacea.
What could go wrong: This is a very small pilot study with only 10 people and no placebo group, so results may not be reliable or apply to everyone. The device is still experimental.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FLUSHING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Flushing rosacea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FLUSHING ROSACEA ROSACEA, ERYTHEMATOTELANGIECTATIC

Contacts and locations

Locations

Brigham and Women's Hospital
RECRUITING

Boston, Massachusetts, 02461, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.